Clinical Trials, End Points, and Statistics—Measuring and Comparing Cancer Treatments in Practice

JAMA Oncology - United States
doi 10.1001/jamaoncol.2018.3708
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Medical Association (AMA)

Related search

End Points and Outcomes in Castration-Resistant Prostate Cancer: From Clinical Trials to Clinical Practice

Journal of Clinical Oncology
Cancer ResearchMedicineOncology
2011English

Are Component Endpoints Equal? A Study Into the Practice of Composite End Points in Clinical Trials

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2016English

Surrogate End Points for Clinical Trials of Kidney Disease Progression

Clinical Journal of the American Society of Nephrology
EpidemiologyNephrologyCritical CareTransplantationIntensive Care Medicine
2006English

Phase II Cancer Clinical Trials for Biomarker-Guided Treatments

Journal of Biopharmaceutical Statistics
StatisticsProbabilityPharmacology
2017English

Bispecific Antibodies in Clinical Practice and Clinical Trials (Literature Review)

Klinicheskaya Onkogematologiya/Clinical Oncohematology
OncologyHematology
2019English

Variable Impact of Combining Fatal and Nonfatal End Points in Heart Failure Trials

Circulation
Cardiovascular MedicinePhysiologyCardiology
2006English

Randomised Clinical Trials in General Practice.

BMJ
1992English

Role of Optic Nerve Imaging in Glaucoma Clinical Practice and Clinical Trials

American Journal of Ophthalmology
Ophthalmology
2008English

Clinical Trials in Preeclampsia: Implications for Practice

Acta Obstetricia et Gynecologica Scandinavica
MedicineGynecologyObstetrics
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy